NM-ADTRAN
28.2.2024 14:01:33 CET | Business Wire | Press release
Adtran today announced that Mescalero Apache Telecom, Inc. (MATI) is harnessing its fiber access solution to bring high-speed connectivity to rural tribal communities in New Mexico. Supported by a mix of loans and grant funds, MATI’s new infrastructure is the first full FTTH XGS-PON network to be built among any tribal nation. Part of the Broadband Infrastructure Deployment initiative, the solution will deliver symmetrical Gigabit services to the Mescalero Apache reservation. The deployment is set to have a significant impact on the community, empowering residents with access to critical online resources such as education, telehealth services and remote work opportunities. Key components of the new network include Adtran’s AI-driven Mosaic One Device Manager and its Oscilloquartz timing and synchronization technology. Adtran’s partner, Netceed, a leading provider of materials, distribution and supply chain management solutions supporting the telecommunications and broadband industry, is also playing a key role in the project.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240228081531/en/
Mescalero Apache Telecom, Inc. is using Adtran’s technology to deliver high-speed broadband services to tribal communities in New Mexico. (Photo: Business Wire)
“Building high-quality internet infrastructure is one of the most effective ways of improving life in tribal communities. That’s why, as part of the award we’ve received to help close the digital divide in New Mexico, we’re connecting 29 community anchor institutions, including libraries and Head Start centers, to our new symmetrical Gigabit services,” said Godfrey Enjady, GM of MATI. “As our trusted and longstanding partner, it’s great to have Adtran by our side as we roll out the first FTTH tribal network using XGS-PON technology. By leveraging their innovation, we’re expanding and enhancing our network with a flexible, scalable platform primed to address today’s connectivity challenges and ready to support tomorrow’s multigigabit demands.”
Adtran’s technology is empowering MATI to seamlessly transition to an XGS-PON network that provides full-fiber and fixed wireless access connectivity. The Total Access 5000 lays the foundations for a robust infrastructure, while Mosaic One streamlines network operations and subscriber device management for efficient, customer-centric service delivery. Adtran’s ONTs are supplying high-speed internet to 835 previously unserved households and 336 business premises. Featuring a 10GbE interface, the compact and powerful devices are also capable of providing premium multigigabit services. For enhanced in-home coverage, Adtran’s high-performance mesh routers deliver extensive and reliable connectivity. And with the precision of Adtran’s Oscilloquartz synchronization technology, the solution ensures a seamless and robust experience for new and existing subscribers.
“We’re proud to support MATI in its mission. What we all share is a commitment to fostering digital inclusivity. It’s crucial that tribal communities are not just connected but also fully equipped with the reliable, high-quality tools and resources necessary to thrive in an increasingly digital world,” commented John Scherzinger, GM of Americas sales at Adtran. “By leveraging our broadband solutions and the dedicated support of the Adtran and Netceed team, MATI is enriching lives and creating new opportunities for learning, growth and development. It’s enabling these previously underserved communities to make digital access a foundational element of their growth and success.”
“At Netceed, a large part of our mission involves connecting the unconnected. As a one-stop shop distribution and solutions partner to our customers, we strive to push the boundaries of technology, helping ensure universal access to digital opportunities,” noted Chet Enos, senior director of sales, south central at Netceed. “The deployment of Adtran’s open and scalable fiber access solution marks a significant advancement for these communities. Working closely together, we’ve been able to equip MATI’s subscribers with the high-quality, ultra-fast broadband they deserve. It’s vital that New Mexico’s rural tribal homes and businesses have affordable access to the same information and resources available in other areas of the country. With its new network, MATI is paving the way for people living in remote regions to benefit from a more connected and prosperous future, and we’re proud to be part of this initiative.”
Further information on how Adtran is helping MATI and its communities is available in this video.
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240228081531/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
